Eternity Insights has published a new study on Global Antibody Drug Conjugate Market focusing on key segments as by Type (Kadcyla,Adcertis, Other), by Application (Biotechnology Companies,Specialized Cancer Centers,Biopharmaceutical Companies,Academic Research Institutes,Hospitals,Others), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Antibody Drug Conjugate Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Antibody Drug Conjugate Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Antibody Drug Conjugate market in terms of demand generation. The Antibody Drug Conjugate market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Antibody Drug Conjugate market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
To learn more about this report
The global Antibody Drug Conjugate market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook | Kadcyla,Adcertis, Other |
| By Application Outlook | Biotechnology Companies,Specialized Cancer Centers,Biopharmaceutical Companies,Academic Research Institutes,Hospitals,Others |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | Takeda Pharmaceutical Company Ltd.,Hoffmann-La Roche Ltd.,Pfizer, Inc.,AstraZeneca,Gilead Sciences, Inc.,Astellas Pharma,Seagen, Inc.,Daiichi Sankyo Company Ltd.,GlaxoSmithKline Plc,ADC Therapeutics |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Antibody Drug Conjugate Introduction and Market Overview
1.1 Objectives of the Study
1.2 Definition of Antibody Drug Conjugate
1.3 Antibody Drug Conjugate Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Antibody Drug Conjugate Value ($) and Growth Rate from 2017-2028
1.4 Market Segmentation
1.4.1 Types of Antibody Drug Conjugate
1.4.2 Applications of Antibody Drug Conjugate
1.4.3 Research Regions
1.4.3.1 North America Antibody Drug Conjugate Production Value ($) and Growth Rate (2017-2020)
1.4.3.2 Europe Antibody Drug Conjugate Production Value ($) and Growth Rate (2017-2020)
1.4.3.3 China Antibody Drug Conjugate Production Value ($) and Growth Rate (2017-2020)
1.4.3.4 Japan Antibody Drug Conjugate Production Value ($) and Growth Rate (2017-2020)
1.4.3.5 Middle East & Africa Antibody Drug Conjugate Production Value ($) and Growth Rate (2017-2020)
1.4.3.6 India Antibody Drug Conjugate Production Value ($) and Growth Rate (2017-2020)
1.4.3.7 South America Antibody Drug Conjugate Production Value ($) and Growth Rate (2017-2020)
1.5 Market Dynamics
1.5.1 Drivers
1.5.1.1 Emerging Countries of Antibody Drug Conjugate
1.5.1.2 Growing Market of Antibody Drug Conjugate
1.5.2 Limitations
1.5.3 Opportunities
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
2 Industry Chain Analysis
2.1 Upstream Raw Material Suppliers of Antibody Drug Conjugate Analysis
2.2 Major Players of Antibody Drug Conjugate
2.2.1 Major Players Manufacturing Base and Market Share of Antibody Drug Conjugate in 2020
2.2.2 Major Players Product Types in 2020
2.3 Antibody Drug Conjugate Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Antibody Drug Conjugate
2.3.3 Raw Material Cost of Antibody Drug Conjugate
2.3.4 Labor Cost of Antibody Drug Conjugate
2.4 Market Channel Analysis of Antibody Drug Conjugate
2.5 Major Downstream Buyers of Antibody Drug Conjugate Analysis
3 Global Antibody Drug Conjugate Market, by Type
3.1 Global Antibody Drug Conjugate Value ($) and Market Share by Type (2017-2020)
3.2 Global Antibody Drug Conjugate Production and Market Share by Type (2017-2020)
3.3 Global Antibody Drug Conjugate Value ($) and Growth Rate by Type (2017-2020)
3.4 Global Antibody Drug Conjugate Price Analysis by Type (2017-2020)
4 Antibody Drug Conjugate Market, by Application
4.1 Global Antibody Drug Conjugate Consumption and Market Share by Application (2017-2020)
4.2 Downstream Buyers by Application
4.3 Global Antibody Drug Conjugate Consumption and Growth Rate by Application (2017-2020)
5 Global Antibody Drug Conjugate Production, Value ($) by Region (2017-2020)
5.1 Global Antibody Drug Conjugate Value ($) and Market Share by Region (2017-2020)
5.2 Global Antibody Drug Conjugate Production and Market Share by Region (2017-2020)
5.3 Global Antibody Drug Conjugate Production, Value ($), Price and Gross Margin (2017-2020)
5.4 North America Antibody Drug Conjugate Production, Value ($), Price and Gross Margin (2017-2020)
5.5 Europe Antibody Drug Conjugate Production, Value ($), Price and Gross Margin (2017-2020)
5.6 China Antibody Drug Conjugate Production, Value ($), Price and Gross Margin (2017-2020)
5.7 Japan Antibody Drug Conjugate Production, Value ($), Price and Gross Margin (2017-2020)
5.8 Middle East & Africa Antibody Drug Conjugate Production, Value ($), Price and Gross Margin (2017-2020)
5.9 India Antibody Drug Conjugate Production, Value ($), Price and Gross Margin (2017-2020)
5.10 South America Antibody Drug Conjugate Production, Value ($), Price and Gross Margin (2017-2020)
6 Global Antibody Drug Conjugate Production, Consumption, Export, Import by Regions (2017-2020)
6.1 Global Antibody Drug Conjugate Consumption by Regions (2017-2020)
6.2 North America Antibody Drug Conjugate Production, Consumption, Export, Import (2017-2020)
6.3 Europe Antibody Drug Conjugate Production, Consumption, Export, Import (2017-2020)
6.4 China Antibody Drug Conjugate Production, Consumption, Export, Import (2017-2020)
6.5 Japan Antibody Drug Conjugate Production, Consumption, Export, Import (2017-2020)
6.6 Middle East & Africa Antibody Drug Conjugate Production, Consumption, Export, Import (2017-2020)
6.7 India Antibody Drug Conjugate Production, Consumption, Export, Import (2017-2020)
6.8 South America Antibody Drug Conjugate Production, Consumption, Export, Import (2017-2020)
7 Global Antibody Drug Conjugate Market Status and SWOT Analysis by Regions
7.1 North America Antibody Drug Conjugate Market Status and SWOT Analysis
7.2 Europe Antibody Drug Conjugate Market Status and SWOT Analysis
7.3 China Antibody Drug Conjugate Market Status and SWOT Analysis
7.4 Japan Antibody Drug Conjugate Market Status and SWOT Analysis
7.5 Middle East & Africa Antibody Drug Conjugate Market Status and SWOT Analysis
7.6 India Antibody Drug Conjugate Market Status and SWOT Analysis
7.7 South America Antibody Drug Conjugate Market Status and SWOT Analysis
8 Competitive Landscape
8.1 Competitive Profile
8.2 Bayer HealthCare
8.2.1 Company Profiles
8.2.2 Antibody Drug Conjugate Product Introduction
8.2.3 Bayer HealthCare Production, Value ($), Price, Gross Margin 2017-2020
8.2.4 Bayer HealthCare Market Share of Antibody Drug Conjugate Segmented by Region in 2020
8.3 Heidelberg Pharma
8.3.1 Company Profiles
8.3.2 Antibody Drug Conjugate Product Introduction
8.3.3 Heidelberg Pharma Production, Value ($), Price, Gross Margin 2017-2020
8.3.4 Heidelberg Pharma Market Share of Antibody Drug Conjugate Segmented by Region in 2020
8.4 Pfizer
8.4.1 Company Profiles
8.4.2 Antibody Drug Conjugate Product Introduction
8.4.3 Pfizer Production, Value ($), Price, Gross Margin 2017-2020
8.4.4 Pfizer Market Share of Antibody Drug Conjugate Segmented by Region in 2020
8.5 Millennium Pharmaceuticals
8.5.1 Company Profiles
8.5.2 Antibody Drug Conjugate Product Introduction
8.5.3 Millennium Pharmaceuticals Production, Value ($), Price, Gross Margin 2017-2020
8.5.4 Millennium Pharmaceuticals Market Share of Antibody Drug Conjugate Segmented by Region in 2020
8.6 Seattle Genetics/Takeda
8.6.1 Company Profiles
8.6.2 Antibody Drug Conjugate Product Introduction
8.6.3 Seattle Genetics/Takeda Production, Value ($), Price, Gross Margin 2017-2020
8.6.4 Seattle Genetics/Takeda Market Share of Antibody Drug Conjugate Segmented by Region in 2020
8.7 Oxford BioTherapeutics
8.7.1 Company Profiles
8.7.2 Antibody Drug Conjugate Product Introduction
8.7.3 Oxford BioTherapeutics Production, Value ($), Price, Gross Margin 2017-2020
8.7.4 Oxford BioTherapeutics Market Share of Antibody Drug Conjugate Segmented by Region in 2020
8.8 Roche
8.8.1 Company Profiles
8.8.2 Antibody Drug Conjugate Product Introduction
8.8.3 Roche Production, Value ($), Price, Gross Margin 2017-2020
8.8.4 Roche Market Share of Antibody Drug Conjugate Segmented by Region in 2020
8.9 Takeda Pharmaceutical Company Limited
8.9.1 Company Profiles
8.9.2 Antibody Drug Conjugate Product Introduction
8.9.3 Takeda Pharmaceutical Company Limited Production, Value ($), Price, Gross Margin 2017-2020
8.9.4 Takeda Pharmaceutical Company Limited Market Share of Antibody Drug Conjugate Segmented by Region in 2020
8.10 Celldex Therapeutics
8.10.1 Company Profiles
8.10.2 Antibody Drug Conjugate Product Introduction
8.10.3 Celldex Therapeutics Production, Value ($), Price, Gross Margin 2017-2020
8.10.4 Celldex Therapeutics Market Share of Antibody Drug Conjugate Segmented by Region in 2020
8.11 Mersana Therapeutics
8.11.1 Company Profiles
8.11.2 Antibody Drug Conjugate Product Introduction
8.11.3 Mersana Therapeutics Production, Value ($), Price, Gross Margin 2017-2020
8.11.4 Mersana Therapeutics Market Share of Antibody Drug Conjugate Segmented by Region in 2020
8.12 ImmunoGen
8.12.1 Company Profiles
8.12.2 Antibody Drug Conjugate Product Introduction
8.12.3 ImmunoGen Production, Value ($), Price, Gross Margin 2017-2020
8.12.4 ImmunoGen Market Share of Antibody Drug Conjugate Segmented by Region in 2020
8.13 Immunomedics
8.13.1 Company Profiles
8.13.2 Antibody Drug Conjugate Product Introduction
8.13.3 Immunomedics Production, Value ($), Price, Gross Margin 2017-2020
8.13.4 Immunomedics Market Share of Antibody Drug Conjugate Segmented by Region in 2020
9 Global Antibody Drug Conjugate Market Analysis and Forecast by Type and Application
9.1 Global Antibody Drug Conjugate Market Value ($) & Volume Forecast, by Type (2021-2028)
9.1.1 Adcetris Market Value ($) and Volume Forecast (2021-2028)
9.1.2 Kadcyl Market Value ($) and Volume Forecast (2021-2028)
9.2 Global Antibody Drug Conjugate Market Value ($) & Volume Forecast, by Application (2021-2028)
9.2.1 Hospital Market Value ($) and Volume Forecast (2021-2028)
9.2.2 Research Institutions Market Value ($) and Volume Forecast (2021-2028)
10 Antibody Drug Conjugate Market Analysis and Forecast by Region
10.1 North America Market Value ($) and Consumption Forecast (2021-2028)
10.2 Europe Market Value ($) and Consumption Forecast (2021-2028)
10.3 China Market Value ($) and Consumption Forecast (2021-2028)
10.4 Japan Market Value ($) and Consumption Forecast (2021-2028)
10.5 Middle East & Africa Market Value ($) and Consumption Forecast (2021-2028)
10.6 India Market Value ($) and Consumption Forecast (2021-2028)
10.7 South America Market Value ($) and Consumption Forecast (2021-2028)
11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment
12 Research Finding and Conclusion
13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Maia Subscription Portal
13.3 Research Data Source
13.4 Research Assumptions and Acronyms Used
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
A faster and efficient way to cater to the needs with continuous iteration
Focus on Data Accuracy & Reliability
75+ Clients in Fortune 500
All your transactions are secured end-to-end, ensuring a satisfactory purchase
Ensure the best and affordable pricing
